Reply by authors: Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore

2019

Urologic Oncology , Volume 37 - Issue 6 p. 341- 342

Additional Metadata
Persistent URL	doi.org/10.1016/j.urolonc.2019.02.007, hdl.handle.net/1765/116762
Journal	Urologic Oncology
Organisation	Department of Urology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Verbeek, J.F.M., & Roobol-Bouts, M. (2019). Reply by authors: Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore. Urologic Oncology, 37(6), 341–342. doi:10.1016/j.urolonc.2019.02.007

Publication